Clinical Trial Update: Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating methotrexate with or without antineoplaston therapy for postmenopausal women with advanced refractory breast cancer has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Antineoplaston therapy
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Burzynski Research Institute | Conditions: Stage IV Breast Cancer, Recurrent Breast Cancer | Phase 2 | Status: WITHDRAWN